Showing results (61-70 of 422) with videos related to

Sort By:
Pageof 43
BMC Developmental Biology|September 21, 2007
Neuregulin3 alters cell fate in the epidermis and mammary glandHeena Panchal, Olivia Wansbury, Suzanne Parry, et al.
The Journal of Pathology|November 6, 2009
Genomic instability and the selection of treatments for cancerSarah A Martin, Madeleine Hewish, Christopher J Lord, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|March 11, 2026
Comparative sequence analysis of the mouse pseudoautosomal region from three inbred strains reveals it to be the most rapidly evolving 'chromosome'Takaoki Kasahara, Kazuyuki Mekada, Kuniya Abe, et al.
Human Molecular Genetics|April 30, 2004
Direct interaction of FANCD2 with BRCA2 in DNA damage response pathwaysShobbir Hussain, James B Wilson, Annette L Medhurst, et al.
Human Molecular Genetics|August 21, 2003
Phenotypic effects of heterozygosity for a BRCA2 mutationMadhuri Warren, Christopher J Lord, Julio Masabanda, et al.
DNA Repair|April 11, 2013
Identification of miRNA modulators to PARP inhibitor responseSari Neijenhuis, Ilirjana Bajrami, Rowan Miller, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Discovery of a Novel [6-6-5-5-6] Pentacyclic Tetrahydrocyclopentaphthalazinone as a Promising PARP Inhibitor ScaffoldYagmur U Doruk, Morgan E Diolaiti, Alan Ashworth, et al.
International Journal of Molecular Sciences|September 25, 2019
Klotho: A Major Shareholder in Vascular Aging EnterprisesKenneth Lim, Arvin Halim, Tzong-Shi Lu, et al.
Nature Communications|April 13, 2019
A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancersGourish Mondal, Meredith Stevers, Benjamin Goode, et al.
Preventive Oncology & Epidemiology|March 25, 2024
Cancer Research in 2030: A unique strategic planning process at a comprehensive cancer centerErin M Bank, Eric J Small, Alan Ashworth, et al.
Pageof 43